Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) : An intensive and effective regimen for patients with aggressive, refractory or recurrent non-Hodgkin lymphomas after anthracycline-containing regimens

ID:am030003M00351470ndcy05221📫 -页
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) : An intensive and effective regimen for patients with aggressive, refractory or recurrent non-Hodgkin lymphomas after anthracycline-containing regimens
⚠ 举报QQ邮箱: 361755509@qq.com⚠ 版权申诉QQ邮箱: 361755509@qq.com

内容摘要

Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) : An intensive and effective regimen for patients with aggressive, refractory or recurrent non-Hodgkin lymphomas after anthracycline-containing regimens

海外数据平台所有内容均是公开网络、AI代理代查、客户上传分享、合作方,仅供网友学习交流,请勿商用!

海外数据(小程序)

微信小程序

请使用微信扫码打开小程序